« Pomalidomide approved for use across Europe Amendments to the pharmacovigilance legislation: new notification requirements… »
Slovak translation of the MPE Report on Myeloma Patient Perspectives is now available Published October 31, 2013 Download your copy here. Recent news» MPE Publishes 2021: Year in Review» ASH 2021| over 50% of myeloma patients reach minimal residual disease negativity with Isatuximab in combination with RVd Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment Name * Email * Website Save my name, email, and website in this browser for the next time I comment. I accept the Privacy Policy
Leave a Reply